Results 81 to 90 of about 1,203 (200)
Repositioning Antimicrobial Peptides Against WHO‐Priority Fungi
The growing burden of drug‐resistant fungal infections, driven by pathogens such as Candida auris, Cryptococcus neoformans, and Aspergillus fumigatus, underscores the urgent need for novel antifungal therapies. This review explores antimicrobial peptides as promising agents with membrane‐disruptive activity, immunomodulatory properties, and delivery ...
Cesar Augusto Roque‐Borda +12 more
wiley +1 more source
Guideline adherence and survival of patients with candidaemia in Europe:results from the ECMM Candida III multinational European observational cohort study [PDF]
Background: The European Confederation of Medical Mycology (ECMM) collected data on epidemiology, risk factors, treatment, and outcomes of patients with culture-proven candidaemia across Europe to assess how adherence to guideline recommendations is ...
core +1 more source
Nakaseomyces glabratus (formerly known as Candida glabrata) is an endogenous opportunistic pathogen that causes various clinical manifestations, ranging from mucocutaneous overgrowth to bloodstream infections. This review aims to summarize the biology, epidemiology and pathology of N.
Carmen Rodríguez‐Cerdeira +8 more
wiley +1 more source
Antifungal Therapy and Probiotics in Women's Health - A Comprehensive Review [PDF]
Candida-induced infections affect millions of women around the world. Therefore, the purpose of this review is to provide a comprehensive analysis of the role of antifungal therapy and probiotics in managing one such infection, vulvovaginal candidiasis ...
Amangeldi, Alma +14 more
core +2 more sources
Enhancing Flucytosine Anticandidal Activity Using PEGylated Squalene Nanocarrier
Our study focused on improving the effectiveness of the antifungal drug 5‐fluorocytosine (5FC) by loading it in micellar structures formed by PEGylated squalene copolymer. The obtained results for 5FC‐loaded micelles showed in vitro prolonged release under physiological conditions and improved in vitro antifungal activity without cytotoxicity for ...
Bogdan‐Florin Craciun +3 more
wiley +1 more source
Aspiring Antifungals: Review of Current Antifungal Pipeline Developments
Invasive fungal infections are associated with significant morbidity and mortality, and their management is restricted to a variety of agents from five established classes of antifungal medication.
Thomas J. Gintjee +2 more
doaj +1 more source
Fungal lung disease encompasses a wide spectrum of organisms and associated clinical conditions, presenting a significant global health challenge. The type and severity of disease are determined by underlying host immunity and infecting fungal strain ...
Agarwal, Ritesh +9 more
core +1 more source
Epidemiological Characterization of Clinical Fungal Isolates from Pauls Stradins Clinical University Hospital, Latvia: : A 4-year Surveillance Report [PDF]
Funding Information: The authors are extremely grateful of the management of Pauls Stradin? Clinical University Hospital (PSCUH) and the supporting hospital and laboratory staff for their support in the present study.
Jain, Nityanand +6 more
core +1 more source
This study offers new possibilities for the development of silica‐based hybrid nanoparticles by microfluidics and highlights the potential combination of curcumin and benzydamine hydrochloride for the treatment of vulvovaginal candidiasis. This disease is a public health challenge due to its reports of high incidence, recurrences and resistance to ...
Gabriela C. Carvalho +15 more
wiley +1 more source
Candida Auris Features and its Treatment: Global Emergency [PDF]
Fungal pathogen Candida auris was identified in 2009, in Japan. Currently, it is identified in 5 continents, in more than 40 countries. Therefore, it is nowadays defined as critical priority pathogen.
Durán, Nelson +2 more
core +2 more sources

